Tisdag 13 Maj | 06:24:15 Europe / Stockholm

Prenumeration

2025-05-11 17:50:00

Redeye retains its positive view of Transtema following a Q1 report with strong growth but a slightly lower y/y margin increase than expected.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/